Year archive

Genmab — 2024 filings

All 204 regulatory filings released by Genmab (GMAB) in 2024, sourced directly from the official regulator.

204 Filings

2024 Period

2024 filings (204)

Filing	Released	Lang
6-K Foreign Filer Report	2024-12-04	English
6-K Foreign Filer Report	2024-12-03	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-12-03	English
Capital/Financing Update 2024 Capital/Financing Update	2024-12-03	English
6-K Foreign Filer Report	2024-12-03	English
Director's Dealing 2024 Director's Dealing	2024-12-03	English
Director's Dealing 2024 Director's Dealing	2024-12-03	English
6-K Foreign Filer Report	2024-11-27	English
6-K Foreign Filer Report	2024-11-21	English
6-K Foreign Filer Report	2024-11-06	English
6-K Foreign Filer Report	2024-10-15	English
Earnings Release 2024 Earnings Release Q3 2024	2024-10-15	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024 Earnings Release Q3 2024	2024-10-15	Danish
6-K Foreign Filer Report	2024-10-04	English
Major Shareholding Notification 2024 Major Shareholding Notification	2024-10-04	English
Major Shareholder Announcement Major Shareholding Notification	2024-10-04	English
6-K Foreign Filer Report	2024-10-01	English
6-K Foreign Filer Report	2024-09-26	English
6-K Foreign Filer Report	2024-09-11	English
6-K Foreign Filer Report	2024-09-10	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-09-10	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2024-09-10	English
6-K Foreign Filer Report	2024-08-21	English
Legal Proceedings Report 2024 Legal Proceedings Report	2024-08-19	English
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma Regulatory Filings	2024-08-19	Danish
6-K Foreign Filer Report	2024-08-14	English
6-K Foreign Filer Report	2024-08-13	English
Director's Dealing 2024 Director's Dealing	2024-08-13	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-08-13	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-08-13	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2024-08-13	English
6-K Foreign Filer Report	2024-08-08	English
6-K Foreign Filer Report	2024-08-08	English
Interim / Quarterly Report 2024 Interim / Quarterly Report H1 2024	2024-08-08	English
Genmab Announces Financial Results for the First Half of 2024 Report Publication Announcement H1 2024	2024-08-08	English
Earnings Release 2024 Earnings Release H1 2024	2024-08-08	English
Genmab Updates 2024 Financial Guidance Earnings Release FY 2024	2024-08-08	English
6-K Foreign Filer Report	2024-08-05	English
Regulatory Filings 2024 Regulatory Filings	2024-08-05	English
Genmab Takes Full Control of Acasunlimab Development Program Regulatory Filings	2024-08-05	English
6-K Foreign Filer Report	2024-07-17	English
Earnings Release 2024 Earnings Release Q2 2024	2024-07-17	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024 Earnings Release Q2 2024	2024-07-17	English
6-K Foreign Filer Report	2024-06-28	English
Regulatory Filings 2024 Regulatory Filings	2024-06-28	English
Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Refractory Follicular Lymphoma Regulatory Filings	2024-06-28	Danish
6-K Foreign Filer Report	2024-06-27	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-06-27	English
Completion of Share Buy-back Program Regulatory Filings	2024-06-27	Danish
Completion of Share Buy-back Program Transaction in Own Shares	2024-06-27	English
6-K Foreign Filer Report	2024-06-27	English
6-K Foreign Filer Report	2024-06-24	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-06-24	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-06-24	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-06-24	Danish
6-K Foreign Filer Report	2024-06-20	English
6-K Foreign Filer Report	2024-06-18	English
Capital/Financing Update 2024 Capital/Financing Update	2024-06-18	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2024-06-18	English
6-K Foreign Filer Report	2024-06-18	English
6-K Foreign Filer Report	2024-06-17	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-06-17	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-06-17	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-06-17	Danish
6-K Foreign Filer Report	2024-06-12	English
6-K Foreign Filer Report	2024-06-11	English
Director's Dealing 2024 Director's Dealing	2024-06-11	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-06-11	English
6-K Foreign Filer Report	2024-06-10	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-06-10	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-06-10	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-06-10	English
6-K Foreign Filer Report	2024-06-03	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-06-03	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-06-03	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-06-03	English
6-K Foreign Filer Report	2024-05-28	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-05-27	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-05-27	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-05-27	Danish
6-K Foreign Filer Report	2024-05-21	English
6-K Foreign Filer Report	2024-05-21	English
M&A Activity 2024 M&A Activity	2024-05-21	English
Genmab Completes Acquisition of ProfoundBio Capital/Financing Update	2024-05-21	Danish
Transaction in Own Shares 2024 Transaction in Own Shares	2024-05-21	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-05-21	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-05-21	English
6-K Foreign Filer Report	2024-05-13	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-05-13	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-05-13	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-05-13	Danish
6-K Foreign Filer Report	2024-05-08	English
6-K Foreign Filer Report	2024-05-07	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-05-07	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2024-05-07	Danish
6-K Foreign Filer Report	2024-05-06	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-05-06	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-05-06	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-05-06	Danish
6-K Foreign Filer Report	2024-05-02	English
6-K Foreign Filer Report	2024-04-30	English
Regulatory Filings 2024 Regulatory Filings	2024-04-30	English
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer Regulatory Filings	2024-04-30	English
6-K Foreign Filer Report	2024-04-29	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-04-29	English
Transactions in Connection with Share Buy-back Program Genmab Regulatory Filings	2024-04-29	Danish
Transactions in Connection with Share Buy-back Program Genmab Transaction in Own Shares	2024-04-29	Danish
6-K Foreign Filer Report	2024-04-22	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-04-22	English
Transactions in Connection with Share Buy-back Program Genmab Transaction in Own Shares	2024-04-22	English
Transactions in Connection with Share Buy-back Program Genmab Transaction in Own Shares	2024-04-22	Danish
6-K Foreign Filer Report	2024-04-16	English
Earnings Release 2024 Earnings Release Q1 2024	2024-04-16	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024 Earnings Release Q1 2024	2024-04-16	Danish
6-K Foreign Filer Report	2024-04-15	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-04-15	English
Transactions in Connection with Share Buy-back Program Genmab Regulatory Filings	2024-04-15	Danish
Transactions in Connection with Share Buy-back Program Genmab Transaction in Own Shares	2024-04-15	English
6-K Foreign Filer Report	2024-04-08	English
Regulatory Filings 2024 Regulatory Filings	2024-04-08	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-04-08	English
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-04-08	Danish
6-K Foreign Filer Report	2024-04-03	English
M&A Activity 2024 M&A Activity	2024-04-03	English
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio M&A Activity	2024-04-03	English
6-K Foreign Filer Report	2024-04-02	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-04-02	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-04-02	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-04-02	English
6-K Foreign Filer Report	2024-03-25	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-03-25	English
Transactions in Connection with Share Buy-back Program Regulatory Filings	2024-03-25	Danish
Transactions in Connection with Share Buy-back Program Transaction in Own Shares	2024-03-25	English
6-K Foreign Filer Report	2024-03-21	English
6-K Foreign Filer Report	2024-03-18	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-03-18	English
Completion of share buy-back program Transaction in Own Shares	2024-03-18	English
Completion of share buy-back program Transaction in Own Shares	2024-03-18	English
6-K Foreign Filer Report	2024-03-15	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-03-15	English
Genmab Announces Initiation of Share Buy-Back Program Transaction in Own Shares	2024-03-15	English
6-K Foreign Filer Report	2024-03-13	English
Director's Dealing 2024 Director's Dealing	2024-03-13	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-03-13	English
6-K Foreign Filer Report	2024-03-13	English
6-K Foreign Filer Report	2024-03-11	English
Regulatory Filings 2024 Regulatory Filings	2024-03-11	English
Transactions in connection with share buy-back program Transaction in Own Shares	2024-03-11	English
Transactions in connection with share buy-back program Transaction in Own Shares	2024-03-11	English
6-K Foreign Filer Report	2024-03-04	English
6-K Foreign Filer Report	2024-03-04	English
Director's Dealing 2024 Director's Dealing	2024-03-04	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-03-04	English
Director's Dealing 2024 Director's Dealing	2024-03-04	English
Transactions in connection with share buy-back program Transaction in Own Shares	2024-03-04	English
Transactions in connection with share buy-back program Transaction in Own Shares	2024-03-04	English
6-K Foreign Filer Report	2024-03-02	English
Director's Dealing 2024 Director's Dealing	2024-03-02	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-03-02	English
Regulatory Filings 2024 Regulatory Filings	2024-03-01	English
6-K Foreign Filer Report	2024-02-29	English
Director's Dealing 2024 Director's Dealing	2024-02-29	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-02-29	English
6-K Foreign Filer Report	2024-02-28	English
6-K Foreign Filer Report	2024-02-27	English
Director's Dealing 2024 Director's Dealing	2024-02-27	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-02-27	English
Share Issue/Capital Change 2024 Share Issue/Capital Change	2024-02-27	English
Capital Increase in Genmab as a Result of Employee Warrant Exercise Share Issue/Capital Change	2024-02-27	English
6-K Foreign Filer Report	2024-02-26	English
6-K Foreign Filer Report	2024-02-26	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-02-26	English
Transactions in connection with share buy-back program Regulatory Filings	2024-02-26	Danish
Transactions in connection with share buy-back program Transaction in Own Shares	2024-02-26	English
6-K Foreign Filer Report	2024-02-24	English
6-K Foreign Filer Report	2024-02-24	English
Director's Dealing 2024 Director's Dealing	2024-02-23	English
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons Director's Dealing	2024-02-23	English
REGISTRATION STATEMENT Registration Form	2024-02-22	English
6-K Foreign Filer Report	2024-02-20	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-02-19	English
Transactions in connection with share buy-back program Transaction in Own Shares	2024-02-19	English
Transactions in connection with share buy-back program Transaction in Own Shares	2024-02-19	English
6-K Foreign Filer Report	2024-02-16	English
6-K Foreign Filer Report	2024-02-14	English
20-F Annual Report FY 2023	2024-02-14	English
6-K Foreign Filer Report	2024-02-14	English
Transaction in Own Shares 2024 Transaction in Own Shares	2024-02-14	English
Genmab Announces Initiation of Share Buy-Back Program Transaction in Own Shares	2024-02-14	English
Annual Report (ESEF) 2023 Annual Report (ESEF) FY 2023	2024-02-14	English
Annual Report 2023 Annual Report FY 2023	2024-02-14	English
Genmab Publishes 2023 Annual Report Report Publication Announcement	2024-02-14	English
SEC SCHEDULE 13G Major Shareholding Notification	2024-02-08	English
Major Shareholding Notification 2024 Major Shareholding Notification	2024-02-02	English
6-K Foreign Filer Report	2024-01-31	English
6-K Foreign Filer Report	2024-01-23	English
Earnings Release 2023 Earnings Release FY 2023	2024-01-23	English
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023 Earnings Release FY 2023	2024-01-23	Danish
6-K Foreign Filer Report	2024-01-23	English
Legal Proceedings Report 2024 Legal Proceedings Report	2024-01-23	English
Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen Legal Proceedings Report	2024-01-23	English
6-K Foreign Filer Report	2024-01-03	English
Director's Dealing 2024 Director's Dealing	2024-01-03	English
Transactions With Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons Director's Dealing	2024-01-03	English

Filings by year

2026 64 filings
2025 190 filings
2024 204 filings
2023 149 filings
2022 190 filings
2021 226 filings
2020 167 filings
2019 213 filings
2018 68 filings
2017 124 filings
2016 229 filings
2015 128 filings
2014 107 filings
2013 132 filings
2012 98 filings
2011 97 filings
2010 133 filings
2009 121 filings
2008 109 filings
2007 70 filings